Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Drug compounders sue over weight loss drugs’ removal from FDA shortage list

by
February 25, 2025
in Health Care
0
Drug compounders sue over weight loss drugs’ removal from FDA shortage list

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug shortage list.

Last week, the FDA officially moved Ozempic and Wegovy off its shortage list four months after the drug was found to available in the U.S. During the time that semaglutide has been on the list, compounding pharmacies were able to sell copycat versions of the drug at a much lower cost, enabling telehealth companies and medical spas to cash in on the high-demand product.

The Outsourcing Facilities Association (OFA), however, is not accepting the shortage is over, stating in its lawsuit filed on Monday that the FDA’s decision to remove semaglutide from the shortage list is “reckless and arbitrary.” The trade group filed a similar lawsuit when tirzepatide, the active ingredient in the GLP-1 drugs Mounjaro and Zepbound, were removed from the drug shortage list.

The OFA’s suit argues that the supply of Ozempic and Wegovy cannot meet current demand and thus the shortage is not over.

“FDA’s Delisting Action will (if it stands) cause OFA’s members to fail to capitalize on their investment. It will destroy their revenues, and those of FarmaKeio, from the sale of compounded drugs that are in acute demand,” the lawsuit stated, referring to a compounding company that is also a plaintiff in the case. “Even if Plaintiffs prevail in this action, they will be unable to recoup lost revenues or profits from the federal government.”

The OFA is asking that the FDA’s decision to remove semaglutide from the shortage list be declared unlawful and that the action be reversed.

The Hill has reached out to the FDA for a response, but federal health agencies typically do not comment on ongoing litigation.

Previous Post

Texas measles outbreak grows to 124

Next Post

Utah on the verge of being the first state to ban fluoride in public water

Next Post
Utah on the verge of being the first state to ban fluoride in public water

Utah on the verge of being the first state to ban fluoride in public water

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    New Hampshire lawmakers give final approval to gender-affirming care ban 

    New Hampshire lawmakers give final approval to gender-affirming care ban 

    June 27, 2025
    FDA expanding COVID vaccine warnings over rare heart side effect

    FDA expanding COVID vaccine warnings over rare heart side effect

    June 27, 2025
    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    June 27, 2025

    Trending

    Montana enshrines abortion access into state constitution

    Montana enshrines abortion access into state constitution

    November 6, 2024
    America’s first severe case of bird flu confirmed in Louisiana

    America’s first severe case of bird flu confirmed in Louisiana

    December 18, 2024
    Should colon cancer screening start at 40? 

    Should colon cancer screening start at 40? 

    July 17, 2024
    RFK Jr. says he has ‘generic list’ of HHS staffers who ‘should move out’

    RFK Jr. says he has ‘generic list’ of HHS staffers who ‘should move out’

    February 14, 2025

    Recent News

    New Hampshire lawmakers give final approval to gender-affirming care ban 

    New Hampshire lawmakers give final approval to gender-affirming care ban 

    June 27, 2025
    FDA expanding COVID vaccine warnings over rare heart side effect

    FDA expanding COVID vaccine warnings over rare heart side effect

    June 27, 2025

    Popular News

    • New Hampshire lawmakers give final approval to gender-affirming care ban 
    • FDA expanding COVID vaccine warnings over rare heart side effect

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.